First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Excedrin Lots On October 7, 2020, GSK Consumer Healthcare requested retailers halt sales of certain Excedrin lots.
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
It seems there is always something new to say when it comes to the hot topic of medical marijuana or “cannabis,” as it’s commo
As Case Management Week c
Download a PDF Version of this Article CCMSI, a large boutique thi
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the